SAB Biotherapeutics Overview
SAB Biotherapeutics Target Price
Analysts' 12-month price predictions for SABS.
Get informed when a big investor buys or sells
+ FollowShare Price
$3.6
Average Target Price
$11.33
214.8% upside
214.8% upside3 analysts in the last 4 months
High: $13 | Low: $10
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-24 | BarclaysEliana Merle | $13 | 261.1% upside |  |
| 2026-05-20 | Jefferies | $11 | 205.6% upside | |
| 2026-05-12 | H.C. WainwrightEmily Bodnar | $10 | 177.8% upside | |
| 2026-01-07 | UBSMichael Yee | $7 | 94.4% upside | |
| 2025-09-17 | Leerink Partners | $7 | 94.4% upside | |
| 2024-06-07 | Loop Capital MarketsKumaraguru Raja | $8 | 122.2% upside | |
| 2024-04-02 | H.C. WainwrightEdward White | $6 | 66.7% upside | |
| 2022-08-11 | Chardan Capital | $3 |  16.7% downside | |